Bath ASU Research Blog

News

Lecanemab: A New Hope for Alzheimer’s Patients.

The road to effective treatments for Alzheimer’s disease has been littered with failures.

However, clinical trials of lecanemab supported by Bath ASU have been heralded as a breakthrough -So what’s different this time?

Student Exam Success…

April 5, 2023

Congratulations to our University placement students Sofia, and Shannon who have passed their NCFE Level 2 Awards in Aseptic Services. [...]

Research

Is This the End of the “mabs”?

September 13, 2022

The first monoclonal antibody to achieve marketing approval was Muromonab in 1986. Since then, monoclonal antibodies have become one of the most successful classes of [...]

Research

ADCs: What are they and why do they matter?

January 20, 2015

This is the first article in a series of five blog posts that will put the ADCs in the spotlight. This article will summarise ADCs [...]

Research

ADCs: Function & Pharmacology

January 22, 2015

This is the second article in a series of five blog posts that are putting ADCs in the spotlight. This article will describe in detail [...]

Graphical representation of therapeutic windows for chemotherapy and ADCs

Research

ADCs: Pros and Cons

January 27, 2015

This is the third article in a series of five blog posts that are putting ADCs in the spotlight. This article will describe the pros [...]

Research

ADCs: Origins and Obstacles

January 28, 2015

This is the fourth article in a series of five blog posts that are putting ADCs in the spotlight. This article will describe the origins [...]

Size and structure comparison of mAb, Fab and scFv

Research

ADCs: Pipeline and Progress

February 3, 2015

This is the fifth article in a series of five blog posts that are putting ADCs in the spotlight. This article will describe ways in [...]

Research

ADC Structure, Safety & Stability, from the 2015 NHS QA Symposium

September 16, 2015

Dr Benjamin Young and Terry Chapman spoke at the annual NHS QA Symposium on 15th September 2015. These are the slides from their talk. [...]

Article Reviews

Research

Monoclonal Antibodies to Mitigate Migraine

May 10, 2018

Chronic migraine is a debilitating disorder that affects roughly one in fifty people globally with the cost to the National Health Service in the UK [...]

Research

Sirukumab Set to Establish New Field

February 6, 2017

The success of protein-based drugs has seen them impact on almost every branch of modern medicine. They are useful modulators of the immune system and [...]

Services

Batch Manufacturing

PS Manufacturing

Extended Stability

Research & News

News

Lecanemab: A New Hope for Alzheimer’s Patients.

Student Exam Success…

Is This the End of the “mabs”?

Research

ADCs: What are they and why do they matter?

ADCs: Function & Pharmacology

ADCs: Pros and Cons

ADCs: Origins and Obstacles

ADCs: Pipeline and Progress

ADC Structure, Safety & Stability, from the 2015 NHS QA Symposium

Article Reviews

Monoclonal Antibodies to Mitigate Migraine

Sirukumab Set to Establish New Field